section name header

Pronunciation

proe-klor-PAIR-a-zeen

Classifications

Therapeutic Classification: antiemetics, antipsychotics

Pharmacologic Classification: phenothiazines

Indications

REMS


Action

  • Alters the effects of dopamine in the CNS.
  • Possesses significant anticholinergic and alpha-adrenergic blocking activity.
  • Depresses the chemoreceptor trigger zone in the CNS.
Therapeutic effects:
  • Diminished nausea and vomiting.

Pharmacokinetics

Absorption: Absorption from tablet is variable; may be better with oral liquid formulations. Well absorbed after IM administration.

Distribution: Widely distributed, high concentrations in the CNS.

Protein Binding: 90%.

Metabolism/Excretion: Highly metabolized by the liver and GI mucosa.

Half-Life: Unknown.

Time/Action Profile

(antiemetic effect)

ROUTEONSETPEAKDURATION
PO30–40 minunknown3–4 hr
Rect60 minunknown3–4 hr
IM10–20 min10–30 min3–4 hr
IVrapid (min)10–30 min3–4 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: ECG changes, hypotension, tachycardia

Derm: photosensitivity, pigment changes, rash

EENT: blurred vision, dry eyes, lens opacities

Endo: galactorrhea

GI: constipation, dry mouth, anorexia, hepatitis, ileus

GU: pink or reddish-brown discoloration of urine, urinary retention

Hemat: AGRANULOCYTOSIS, leukopenia

Metab: hyperthermia

Neuro: extrapyramidal reactions, NEUROLEPTIC MALIGNANT SYNDROME, sedation, tardive dyskinesia

Misc: allergic reactions

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Compazine, Compro

Canadian Brand Names

Prochlorazine

Code

NDC Code